A Phase III, Open-Label, Randomized Study of Perioperative Dostarlimab Monotherapy versus Standard of Care in Participants with Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

Brief Summary

Type:
Colorectal

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT05855200

Study #:
STUDY00160331

Start Date:
Sep 19, 2024

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05855200

View Complete Trial Details & Eligibility at ClinicalTrials.gov